Clinical Trials Sponsored by Foundation for OCD Research

Total 1700 results

Massachusetts General Hospital
Foundation for OCD Research

Recruiting

Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD

Obsessive-Compulsive Disorder

United States
Stanford University
Cornell University; Foundation for OCD Research

Recruiting

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

Obsessive-Compulsive Disorder

United States
Michael J. Fox Foundation for Parkinson's Research

Recruiting

Parkinson Progression Marker Initiative Online (PPMI Online)

Parkinson Disease

United States
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Parkinson Disease

United States
Foundation for Liver Research

Completed

Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus

Liver Disease

Netherlands
Foundation for Liver Research

Completed

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

Hepatitis C

Netherlands
Foundation for Liver Research

Completed

Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B (ARES)

Chronic Hepatitis B

Netherlands, China, Romania, Turkey, Poland
Foundation for Liver Research

Completed

Colesevelam Versus Placebo in Cholestatic Pruritus (COPE)

Chronic Liver Disease

Netherlands
Foundation for Liver Research

Completed

Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's (Adafi)

Crohn's Disease With Perianal Fistulas

Netherlands
Foundation for Liver Research

Completed

Entecavir for Chronic Hepatitis B

Entecavir for Chronic Hepatitis B Patients

Netherlands
Foundation for Liver Research

Completed

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B

Netherlands
Foundation for Liver Research

Completed

KRN7000 in Chronic Hepatitis B

Hepatitis B, Chronic

Netherlands
Foundation for Sarcoidosis Research

Recruiting

Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)

Sarcoidosis

United States
Foundation for Liver Research

Completed

Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB (PEGON)

Chronic Hepatitis B

Netherlands, China
Foundation for Liver Research

Completed

Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients (ImmunoDual)

Chronic Hepatitis C

Netherlands
Foundation for Liver Research

Completed

Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study (GIANT-B)

Chronic Hepatitis B

Netherlands
Foundation for Liver Research

Withdrawn

Pancreatic Enzyme Suppletion in Pancreatic Cancer (EPC)

Adenocarcinoma of the Pancreas | Normal Pancreatic Exocrine Function

Netherlands
Foundation for Liver Research

Completed

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders (SCIN-C)

Chronic Hepatitis C

Netherlands
Foundation for Sarcoidosis Research

Recruiting

Routine Cardiac Screening in Sarcoidosis Patients (PAPLAND)

Sarcoidosis | Cardiac Sarcoidosis | Boeck's Disease | Besnier-Boeck Disease

United States, United Kingdom, Netherlands
Foundation for Liver Research

Completed

Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures (COPAC)

Esophageal Cancer | Esophageal Stenosis

Netherlands
Foundation for Liver Research

Completed

Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. (CIRES)

Hepatitis C | Immunology | Liver | Regulation

Netherlands
Foundation for Liver Research

Completed

PEG-IFN in HBV Patients With Incomplete Response to NA (PADD)

Chronic Hepatitis B

Netherlands
Foundation for Liver Research

Completed

Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

Hepatitis C

Netherlands
Foundation for Liver Research

Completed

Long Term Follow-up of Pegylated-Interferon Alpha-2b

Chronic Hepatitis B

Netherlands
Foundation for Liver Research

Completed

Pegintron Induction Therapy in HCV Non-Responders

Hepatitis C

Netherlands
Takeda
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study of TAK-071 in People With Parkinson Disease

Parkinson Disease | Healthy Participants

United States
Michael J. Fox Foundation for Parkinson's Research
Sanofi

Terminated

A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease

Parkinson's Disease

United States
Egyptian Foundation For Cancer Research

Completed

Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma (MERITS)

Metastatic Renal Cell Carcinoma

Egypt
Foundation for Cardiovascular Research, Zurich

Unknown

Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison

Coronary Artery Disease
National Foundation for Fertility Research

Completed

An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro

Infertility | Reproductive Techniques, Assisted

United States
Foundation for Southwest Orthopedic Research

Completed

A Comparative Study of Incision Closure Methods for Total Knee Replacement

Wound Closure | Total Knee Replacement Closure

United States
Foundation for Southwest Orthopedic Research

Completed

A Comparative Study of Knee Systems (Bake-Off)

Osteoarthritis of the Knee

United States
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders

Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort (PPMI)

Parkinson Disease

United States, Canada, Spain, Israel, Austria, Germany, Greece, Italy, Netherlands, Nigeria, United Kingdom, Luxembourg
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders

Completed

PPMI Tau PET Imaging

Parkinson Disease

United States
NeuroDerm Ltd.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients

Parkinson's Disease

Israel
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

Dementia | Alzheimer Disease

United States
Alkahest, Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

Parkinson Disease

United States, France, Australia
Columbia University
Michael J. Fox Foundation for Parkinson's Research

Completed

Antigen Presentation and Lymphocyte Response in Parkinson's Disease

Parkinson's Disease

United States
Emory University
Michael J. Fox Foundation for Parkinson's Research

Completed

Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

Parkinson's Disease

United States
Indiana University
Michael J. Fox Foundation for Parkinson's Research

Completed

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2) (PROGENI)

Parkinson Disease

United States, Canada
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Recruiting

A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's

Parkinson Disease

United States
Yale University
Fox (Michael J.) Foundation for Parkinson's Research

Recruiting

Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD)

Depression | Parkinson's Disease

United States
Avanir Pharmaceuticals
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (LID in PD)

Parkinson's Disease | Dyskinesia

Canada, United States
Acorda Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Idiopathic Parkinson's Disease

Israel, Serbia, United Kingdom
Bastyr University
Michael J. Fox Foundation for Parkinson's Research

Completed

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease ((in)GSH)

Parkinson's Disease

United States
Weill Medical College of Cornell University
The New Venture Fund / Foundation for OCD Research; The Wellcome Leap Fund

Recruiting

Accelerated TMS for Depression and OCD

Depression | OCD

United States
Norconnect Inc
Michael J. Fox Foundation for Parkinson's Research

Completed

Electromyography Signals as Biomarkers for Parkinson's Disease

Parkinson's Disease

United States
Research Foundation for Mental Hygiene, Inc.
FDC Foundation

Completed

Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease

Quality of Life | Fatigue

United States
Research Foundation for Mental Hygiene, Inc.

Completed

Attention-Bias Modification Treatment for PTSD

Posttraumatic Stress Disorder (PTSD)

United States
Research Foundation for Mental Hygiene, Inc.

Completed

HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics

Mental and Behavioral Disorders Due to Harmful Drug Use

United States

Clinical Trials Sponsored by Foundation for OCD Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations